World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000002891
Date of registration: 14/12/2009
Prospective Registration: No
Primary sponsor: National Center for Geriatrics and Gerontology
Public title: A study on the prevention of postoperative delirium for the elderly
Scientific title: A study on the prevention of postoperative delirium for the elderly - A study on the prevention of postoperative delirium for the elderly
Date of first enrolment: 2009/12/01
Target sample size: 120
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003526
Study type:  Interventional
Study design:  Parallel Randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Shinji Fukata
Address:  Gengo 35, Morioka-cho, Obu-city, Aichi, Japan Japan
Telephone: 0562-46-2311
Email: fukatash@ncgg.go.jp
Affiliation:  National Center for Geriatrics and Gerontology Departmentof Surgery
Name:     Shinji Fukata
Address:  Gengo 35, Morioka-cho, Obu-city, Aichi, Japan Japan
Telephone: 0562-46-2311
Email: fukatash@ncgg.go.jp
Affiliation:  National Center for Geriatrics and Gerontology Departmentof Surgery
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: A patient with emergency surgery, or the case that haloperidol treatment intervention is performed on the 0th postoperative day (the day of operation)

Age minimum: 75years-old
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
postoperative delirium
Intervention(s)
In the intervention group, Haloperidol 2.5mg intravenous drip infusion will be performed from postoperative day 1 to day 3
Only serial observations will be applied to the control group
Primary Outcome(s)
We chase psychological disorders / abnormal behavior assessed with NEECHAM score from preoperative day to postoperative day 7 consecutively
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Ministry of Health, Labour and Welfare (Resarch Grant for Longevity Sciences)
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history